BoBER: web interface to the base of bioisosterically exchangeable replacements

We describe a novel freely available web server Base of Bioisosterically Exchangeable Replacements (BoBER), which implements an interface to a database of bioisosteric and scaffold hopping replacements. Bioisosterism and scaffold hopping are key concepts in drug design and optimization, and can be defined as replacements of biologically active compound’s fragments with other fragments to improve activity, reduce toxicity, change bioavailability or to diversify the scaffold space. Our web server enables fast and user-friendly searches for bioisosteric and scaffold replacements which were obtained by mining the whole Protein Data Bank. The working of the web server is presented on an existing MurF inhibitor as example. BoBER web server enables medicinal chemists to quickly search for and get new and unique ideas about possible bioisosteric or scaffold hopping replacements that could be used to improve hit or lead drug-like compounds.

[1]  István Ujváry,et al.  Bioster: A Database of Bioisosteres and Bioanalogues , 2012 .

[2]  Raed Khashan.  FragVLib a free database mining software for generating "Fragment-based Virtual Library" using pocket similarity search of ligand-receptor complexes , 2012, Journal of Cheminformatics.

[3]  Dusanka Janezic,et al.  ProBiS algorithm for detection of structurally similar protein binding sites by local structural alignment , 2010, Bioinform..

[4]  Peter Ertl,et al.  JSME: a free molecule editor in JavaScript , 2013, Journal of Cheminformatics.

[5]  Dusanka Janezic,et al.  ProBiS-ligands: a web server for prediction of ligands by examination of protein binding sites , 2014, Nucleic Acids Res..

[6]  Steven E. Brenner,et al.  The value of protein structure classification information—Surveying the scientific literature , 2015, Proteins.

[7]  Dusanka Janezic,et al.  ProBiS-2012: web server and web services for detection of structurally similar binding sites in proteins , 2012, Nucleic Acids Res..

[8]  Dusanka Janezic,et al.  LiSiCA: A Software for Ligand-Based Virtual Screening and Its Application for the Discovery of Butyrylcholinesterase Inhibitors , 2015, J. Chem. Inf. Model..

[9]  P. Hajduk,et al.  Structure of MurF from Streptococcus pneumoniae co‐crystallized with a small molecule inhibitor exhibits interdomain closure , 2005, Protein science : a publication of the Protein Society.

[10]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[11]  Dusanka Janezic,et al.  ProBiS: a web server for detection of structurally similar protein binding sites , 2010, Nucleic Acids Res..

[12]  K. Comess,et al.  An Ultraefficient Affinity-Based High-Throughout Screening Process: Application to Bacterial Cell Wall Biosynthesis Enzyme MurF , 2006, Journal of biomolecular screening.

[13]  Dušanka Janežič,et al.  Scaffold hopping and bioisosteric replacements based on binding site alignments , 2016 .

[14]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[15]  Nathan Brown.  Bioisosteres and Scaffold Hopping in Medicinal Chemistry , 2014, Molecular informatics.

[16]  Dusanka Janezic,et al.  ProBiS-Database: Precalculated Binding Site Similarities and Local Pairwise Alignments of PDB Structures , 2012, J. Chem. Inf. Model..

[17]  Peter Willett,et al.  Identification of target-specific bioisosteric fragments from ligand–protein crystallographic data , 2006, J. Comput. Aided Mol. Des..

[18]  Nathan Brown,et al.  Bioisosteres in Medicinal Chemistry: BROWN:BIOISOSTERES MED CH O-BK , 2012 .

[19]  S. Turk,et al.  Biochemical characterization of MurF from Streptococcus pneumoniae and the identification of a new MurF inhibitor through ligand-based virtual screening. , 2013, Acta chimica Slovenica.

[20]  Andrew G. Leach,et al.  Matched molecular pair analysis in drug discovery. , 2013, Drug discovery today.

[21]  Sophie Papst,et al.  Bioisosteres In Medicinal Chemistry , 2016 .

[22]  Olivier Michielin,et al.  SwissBioisostere: a database of molecular replacements for ligand design , 2012, Nucleic Acids Res..

[23]  M. Anderluh,et al.  Design, synthesis and evaluation of second generation MurF inhibitors based on a cyanothiophene scaffold. , 2014, European journal of medicinal chemistry.

[24]  S. Turk,et al.  Structure-activity relationships of new cyanothiophene inhibitors of the essential peptidoglycan biosynthesis enzyme MurF. , 2013, European journal of medicinal chemistry.

[25]  Tina Ritschel,et al.  Pharmacophore Fingerprint-Based Approach to Binding Site Subpocket Similarity and Its Application to Bioisostere Replacement , 2012, J. Chem. Inf. Model..

[26]  S. Sethy,et al.  THE ROLE OF BIOISOSTERISM IN MOLECULAR MODIFICATION AND DRUG DESIGN: A REVIEW , 2013 .

[27]  Didier Rognan,et al.  sc-PDB-Frag: A Database of Protein-Ligand Interaction Patterns for Bioisosteric Replacements , 2014, J. Chem. Inf. Model..

[28]  Peter Ertl,et al.  Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization , 2010, Molecular informatics.